Methodology of clinical trials aimed at assessing interventions for cutaneous leishmaniasis.
The current evidence-base for recommendations on the treatment of cutaneous leishmaniasis (CL) is generally weak. Systematic reviews have pointed to a general lack of standardization of methods for the conduct and analysis of clinical trials of CL, compounded with poor overall quality of several tri...
Main Authors: | Piero Olliaro, Michel Vaillant, Byron Arana, Max Grogl, Farrokh Modabber, Alan Magill, Olivier Lapujade, Pierre Buffet, Jorge Alvar |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | http://europepmc.org/articles/PMC3605149?pdf=render |
Similar Items
-
Towards a better understanding of cutaneous leishmaniasis in Guatemala
by: Figueroa, Byron Alfredo Arana
Published: (1998) -
A Review: The Current In Vivo Models for the Discovery and Utility of New Anti-leishmanial Drugs Targeting Cutaneous Leishmaniasis.
by: Emily Rose Mears, et al.
Published: (2015-01-01) -
Harmonized clinical trial methodologies for localized cutaneous leishmaniasis and potential for extensive network with capacities for clinical evaluation.
by: Piero Olliaro, et al.
Published: (2018-01-01) -
Route map for the discovery and pre-clinical development of new drugs and treatments for cutaneous leishmaniasis
by: Diana Caridha, et al.
Published: (2019-12-01) -
Liposomal amphotericin B in travelers with cutaneous and muco-cutaneous leishmaniasis: Not a panacea.
by: Romain Guery, et al.
Published: (2017-11-01)